We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Adding patent foramen ovale closure to antiplatelet drugs reduced ischemic stroke after cryptogenic stroke.
- Authors
Alberts, Mark J.
- Abstract
Source Citation: Søndergaard L, Kasner SE, Rhodes JF, et al; Gore REDUCE Clinical Study Investigators. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017;377:1033-42. 28902580 Clinical Impact Ratings: Hospitalists: <graphic></graphic> Cardiology: <graphic></graphic> Neurology: <graphic></graphic>
- Subjects
PLATELET aggregation inhibitors; ATRIAL fibrillation risk factors; STROKE risk factors; INFARCTION; ISCHEMIA; DISEASE risk factors; DISEASE relapse prevention; PATENT foramen ovale; CEREBRAL ischemia; STROKE; TRANSIENT ischemic attack
- Publication
Annals of Internal Medicine, 2018, Vol 168, Issue 2, pJC6
- ISSN
0003-4819
- Publication type
journal article
- DOI
10.7326/ACPJC-2018-168-2-006